Group 1 - The company, Brainstorm Cell Therapeutics Inc. (6681.HK), plans to issue 92 million shares through a placement, representing approximately 6.77% of the enlarged share capital [1] - The placement price is set at HKD 5.6 per share, which is a discount of about 12.09% compared to the closing price of HKD 6.37 from the previous day [1] - The total funds raised are expected to be HKD 515 million, with a net amount of approximately HKD 501 million after expenses [1] Group 2 - Approximately 50% of the net proceeds will be allocated to research and development initiatives [1] - About 30% of the funds will be used for domestic and international market development [1] - The remaining 20% will be split between strategic investments and acquisitions (10%) and general corporate operational expenses (10%) [1]
脑动极光折让12%配股 筹逾5亿港元